Acino competitive analysis

Explore patent oppositions filed by Acino against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
Pharmaceutical Preparation Containing Oxycodone And NaloxoneEURO CELTIQUEJul 3, 2017
Pharmaceutical Preparation Containing Oxycodone And NaloxoneEURO CELTIQUEJul 3, 2017
Pharmaceutical Preparation Containing Oxycodone And NaloxoneEURO CELTIQUEApr 13, 2017
Pharmaceutical Preparation Containing Oxycodone And NaloxoneEURO CELTIQUEFeb 12, 2016
Pharmaceutical Dosage Form Comprising Oxycodone Hydrochloride Having Less Than 25 Ppm 14-HydroxycodeinoneEURO CELTIQUEOct 26, 2015

Explore Acino's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
Jan 15, 2025Lattice Loss Reduction1

Latest PTAB cases involving Acino

Discover the latest PTAB cases involving Acino, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Acino with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ACINO PHARMA AG5 - - -
EURO CELTIQUE - 73 - -
MUNDIPHARMA235 - -
NAPP PHARMACEUTICAL - 35 - -